Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m641 · Cited by 727

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Section of Precision Medicine Group of Chinese Society of Cardiology, Wang, D. W., Editorial Board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis, Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ye-xin, M., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9385-3 · Cited by 128

Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19

da Silva, S. J. R., da Silva, C. T. A., Guarines, K. M., Mendes, R. P. G., Pardee, K., Kohl, A., & Pena, L. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00274 · Cited by 95

Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review

Huang, C., Soleimani, J., Herasevich, S., Pinevich, Y., Pennington, K. M., Dong, Y., Pickering, B. W., & Barwise, A. K. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.10.022 · Cited by 88

Obesity in COVID-19: A Systematic Review and Meta-analysis

Ho, J. S. Y., Fernando, D. I., Chan, M. Y., & Sia, C. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2020299 · Cited by 93

Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy

Li, X., Shao, M., Zeng, X., Qian, P., & Huang, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00764-4 · Cited by 94

Interleukin-6 blockade for severe COVID-19Preprint

Roumier, M., Paule, R., Groh, M., Vallée, A., Ackermann, F., & for the Foch COVID-19 Study Group (2020) · medRxiv · doi:10.1101/2020.04.20.20061861 · Cited by 89

A multiple-hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19

Goud, P. T., Bai, D., & Abu-Soud, H. M. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.51811 · Cited by 88

Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes

Jain, R., Ramaswamy, S., Harilal, D., Uddin, M. J., Loney, T., Nowotny, N. R., Suwaidi, H. S. A., Varghese, R. M., Deesi, Z., AlKhajeh, A. S., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.016 · Cited by 87

Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)

Norooznezhad, A. H., & Mansouri, K. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104188 · Cited by 88

SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney

Francis, M. E., Goncin, U., Kroeker, A., Swan, C. L., Ralph, R., Lu, Y. W. W., Etzioni, A. L., Falzarano, D., Gerdts, V., Machtaler, S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009705 · Cited by 88

Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19

Syed, F., Li, W., Relich, R. F., Russell, P. M., Zhang, S., Zimmerman, M. K., & Yu, Q. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab167 · Cited by 93

Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y la Sociedad Española de Geriatría y Gerontología

Bonanad, C., García‐Blas, S., Tarazona‐Santabalbina, F. J., Díez‐Villanueva, P., Ayesta, A., Forés, J. S., Vidán-Austiz, M. T., Formiga, F., Ariza‐Solé, A., Martínez‐Sellés, M., et al. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.03.027 · Cited by 87

Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States

Kates, O. S., Fisher, C. E., Karita, H. C. S., Shepherd, A., Church, E. C., Kapnadak, S. G., Lease, E. D., Riedo, F. X., Rakita, R. M., & Limaye, A. P. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15944 · Cited by 87

Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020

Ferguson, J., Rosser, J. I., Quintero, O., Scott, J. A., Subramanian, A. K., Gumma, M. E. F., Rogers, A. J., & Kappagoda, S. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201776 · Cited by 87

Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin

Alunno, A., Carubbi, F., & Rodríguez‐Carrio, J. (2020) · RMD Open · doi:10.1136/rmdopen-2020-001295 · Cited by 93

SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation

Grandbastien, M., Piotin, A., Godet, J., Abessolo-Amougou, I., Ederlé, C., Enache, I., Fraisse, P., Hoang, T.-C.-T., Kassègne, L., Labani, A., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.06.032 · Cited by 87

Management of Respiratory Distress Syndrome due to COVID-19 infection

Navas‐Blanco, J. R., & Dudaryk, R. (2020) · BMC Anesthesiology · doi:10.1186/s12871-020-01095-7 · Cited by 89

Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission

Battagello, D. S., Dragunas, G., Klein, M., Ayub, A. L. P., Velloso, F. J., & Correa, R. G. (2020) · Clinical Science · doi:10.1042/cs20200904 · Cited by 88

Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises

Hossain, K. S., Hossain, M. G., Moni, A., Rahman, M. M., Rahman, U. H., Alam, M., Kundu, S., Rahman, M. M., Hannan, M. A., & Uddin, M. J. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05798 · Cited by 101

A State-of-the-Art Scoping Review on SARS-CoV-2 in Sewage Focusing on the Potential of Wastewater Surveillance for the Monitoring of the COVID-19 Pandemic

Ferraro, G. B., Veneri, C., Mancini, P., Iaconelli, M., Suffredini, E., Bonadonna, L., Lucentini, L., Bowo‐Ngandji, A., Kengne-Ndé, C., Mbaga, D. S., et al. (2021) · Food and Environmental Virology · doi:10.1007/s12560-021-09498-6 · Cited by 87

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers

Galán, M. Á., Vigón, L., Fuertes, D., Murciano-Antón, M. A., Casado‐Fernández, G., Domínguez-Mateos, S., Mateos, E., Ramos-Martín, F., Planelles, V., Torres, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848886 · Cited by 92

Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury

Sarzani, R., Giulietti, F., Di Pentima, C., Giordano, P., & Spannella, F. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00189.2020 · Cited by 86

Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19

Ullah, W., Basyal, B., Tariq, S., Almas, T., Saeed, R., Roomi, S., Haq, S., Madara, J., Boigon, M. I., Haas, D. C., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4227 · Cited by 86

Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study

Zang, X., Wang, Q., Zhou, H., Liu, S., Xue, X., COVID-19 Early Prone Position Study Group, Zhang, W., Gao, Q., Xie, J., Jiang, C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06182-4 · Cited by 86

The prognostic value of the SOFA score in patients with COVID-19

Yang, Z., Hu, Q., Huang, F., Xiong, S., & Sun, Y. (2021) · Medicine · doi:10.1097/md.0000000000026900 · Cited by 87

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations

Thepmankorn, P., Bach, J. R., Lasfar, A., Zhao, X., Souayah, S., Chong, Z. Z., & Souayah, N. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155404 · Cited by 89

Specialized interferon action in COVID-19

Galbraith, M. D., Kinning, K. T., Sullivan, K. D., Araya, P., Smith, K. P., Granrath, R. E., Shaw, J. R., Baxter, R. M., Jordan, K. R., Russell, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116730119 · Cited by 84

Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight

Higham, A., & Singh, D. (2020) · Obesity · doi:10.1002/oby.22907 · Cited by 85

Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus

Renieris, G., Katrini, K., Damoulari, C., Akinosoglou, K., Psarrakis, C., Kyriakopoulou, M., Dimοpoulos, G., Lada, M., Koufargyris, P., & Giamarellos‐Bourboulis, E. J. (2020) · Shock · doi:10.1097/shk.0000000000001562 · Cited by 88

A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome

Khiali, S., Khani, E., & Entezari‐Maleki, T. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1693 · Cited by 87

Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection

Keam, S., Megawati, D., Patel, S. K., Tiwari, R., Dhama, K., & Harapan, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2123 · Cited by 85

COVID-19–Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?

Görlinger, K., Dirkmann, D., Gandhi, A., & Simioni, P. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005147 · Cited by 86

Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

Franzini, M., Valdenassi, L., Ricevuti, G., Chirumbolo, S., Depfenhart, M., Bertossi, D., & Tirelli, U. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106879 · Cited by 85

Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports

Soumya, R. S., Unni, T. G., & Raghu, K. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07073-y · Cited by 92

Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019

Espíndola, O. D. M., Gomes, Y. C. P., Brandão, C. O., Torres, R. C., Siqueira, M. M., Soares, C., Lima, M. A., Leite, A. C. C. B., Venturotti, C. O., Carvalho, A. J. C., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26041 · Cited by 85

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84

The Pathophysiology of Long COVID throughout the Renin-Angiotensin System

Khazaal, S., Harb, J., Rima, M., Annweiler, C., Wu, Y., Cao, Z., Khattar, Z. A., Legros, C., Kovacic, H., Fajloun, Z., et al. (2022) · Molecules · doi:10.3390/molecules27092903 · Cited by 87

Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic

Han, Y., Chen, T., Bryant, J., Bucciarelli‐Ducci, C., Dyke, C. K., Elliott, M. D., Ferrari, V. A., Friedrich, M. G., Lawton, C. B., Manning, W. J., et al. (2020) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-020-00628-w · Cited by 83

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 83

Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis

Klinger, D., Blass, I., Rappoport, N., & Michal Linial, B. (2020) · Vaccines · doi:10.3390/vaccines8030378 · Cited by 85

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

Opoka‐Winiarska, V., Grywalska, E., & Roliński, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01682-y · Cited by 84

The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis

Luo, L., Fu, M., Li, Y., Hu, S., Luo, J., Chen, Z., Yu, J., Li, W., Dong, R., Yang, Y., et al. (2020) · Clinical Cardiology · doi:10.1002/clc.23465 · Cited by 84

MENTAL HEALTH OUTCOMES OF ADULTS WITH COMORBIDITY AND CHRONIC DISEASES DURING THE COVID-19 PANDEMIC: A MATCHED CASE-CONTROL STUDY

Sayeed, A., Kundu, S., Banna, M. H. A., Christopher, E., Hasan, M. T., Begum, M. R., Chowdhury, S., & Khan, M. S. I. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.491 · Cited by 89

Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19

Neumann, J., Prezzemolo, T., Vanderbeke, L., Roca, C. P., Gerbaux, M., Janssens, S., Willemsen, M., Burton, O. T., Mol, P. V., Herck, Y. V., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1204 · Cited by 84

Spatial analysis of the impact of urban geometry and socio-demographic characteristics on COVID-19, a study in Hong Kong

Kwok, C. Y. T., Wong, M. S., Chan, K. L., Kwan, M., Nichol, J. E., Liu, C. H., Wong, J. Y. H., Wai, A. K. C., Chan, L., Xu, Y., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.144455 · Cited by 84

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19

Venditto, V. J., Haydar, D., Abdel‐Latif, A., Gensel, J. C., Anstead, M., Pitts, M. G., Creameans, J. W., Kopper, T. J., Peng, C., & Feola, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.574425 · Cited by 90

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 84

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

Katsiki, N., Banach, M., & Mikhailidis, D. P. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.94503 · Cited by 85

COVID-19: Review and hematologic impact

Toledo, S. L. D. O., Nogueira, L. S., Ferriani, M. D. G. C., Rios, D. R. A., & Pinheiro, M. D. B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.016 · Cited by 91

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Montesarchio, V., Parrella, R., Iommelli, C., Bianco, A., Manzillo, E., Fraganza, F., Palumbo, C., Rea, G., Murino, P., Rosa, R. C. D., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001089 · Cited by 84

Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID ‐19 prevention and cure

Islam, M. N., Hossain, K. S., Sarker, S., Ferdous, J., Hannan, M. A., Rahman, M. M., Chu, D., & Uddin, M. J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6895 · Cited by 91

Red cell distribution width (RDW): a prognostic indicator of severe COVID-19

Wang, C., Zhang, H., Cao, X., Deng, R., Ye, Y., Fu, Z., Gou, L., Shao, F., Li, J., Fu, W., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-6090 · Cited by 83

Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients

Al‐Khawaga, S., & Abdelalim, E. M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01963-6 · Cited by 84

Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

Kaur, R. J., Charan, J., Dutta, S., Sharma, P., Bhardwaj, P., Sharma, P., Lugova, H., Krishnapillai, A. D. S., Islam, S., Haque, M., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s287934 · Cited by 83

Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms

Garren, M. R. S., Ashcraft, M. M., Qian, Y., Douglass, M. E., Brisbois, E. J., & Handa, H. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100887 · Cited by 88

Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review

Tabari, M. A. K., Iranpanah, A., Bahramsoltani, R., & Rahimi, R. (2021) · Molecules · doi:10.3390/molecules26133900 · Cited by 85

„Coronavirus disease 2019“ (COVID-19): update für Anästhesisten und Intensivmediziner März 2020

Thomas-Rüddel, D. O., Winning, J., Dickmann, P., Ouart, D., Kortgen, A., Janssens, U., & Bauer, M. W. (2020) · Der Anaesthesist · doi:10.1007/s00101-020-00758-x · Cited by 82

Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study

Bolondi, G., Russo, E., Gamberini, E., Circelli, A., Meca, M. C. C., Brogi, E., Viola, L., Bissoni, L., Poletti, V., & Agnoletti, V. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00323-2 · Cited by 82

Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study

Cornejo-Pareja, I. M., Vegas-Aguilar, I. M., García‐Almeida, J. M., Bellido, D., Talluri, A., Lukaski, H. C., & Tinahones, F. J. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.017 · Cited by 82

Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study

Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 84

COVID‐19 and liver dysfunction: A systematic review and meta‐analysis of retrospective studies

Youssef, M. R., Hussein, M. H., Attia, A. S., Elshazli, R. M., Omar, M., Zora, G., Farhoud, A. S., Elnahla, A., Shihabi, A., Toraih, E. A., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26055 · Cited by 81

ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review

Cho, H. J., Heinsar, S., Jeong, I. S., Shekar, K., Bassi, G. L., Jung, J. S., Suen, J. Y., & Fraser, J. F. (2020) · Critical Care · doi:10.1186/s13054-020-02979-3 · Cited by 83

Chronic Hemodialysis Patients Hospitalized with COVID-19: Short-term Outcomes in the Bronx, New York

Fisher, M. C., Yunes, M., Mokrzycki, M. H., Golestaneh, L., Alahiri, E., & Coco, M. (2020) · Kidney360 · doi:10.34067/kid.0003672020 · Cited by 81

Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States

Parcha, V., Kalra, R., Bhatt, S. P., Berra, L. M., Arora, G., & Arora, P. K. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.10.042 · Cited by 81

An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts

Yang, L., Han, Y., Jaffré, F., Nilsson-Payant, B. E., Bram, Y., Wang, P., Zhu, J., Zhang, T., Redmond, D., Houghton, S., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319060 · Cited by 83

Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19

Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M. E., Yang, L., Sivapatham, S., Jacobs, A., Baechli, E., Rudiger, A., et al. (2021) · Allergy · doi:10.1111/all.14866 · Cited by 83

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets

Hazeldine, J., & Lord, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680134 · Cited by 86

Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS)

Sikora, J. P., Karawani, J., & Sobczak, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713469 · Cited by 98

Repurposing anticancer drugs for the management of COVID-19

Bairi, K. E., Trapani, D., Petrillo, A., Page, C. L., Zbakh, H., Daniele, B., Belbaraka, R., Curigliano, G., & Afqir, S. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.014 · Cited by 82

DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists

Naqvi, I. A., Giroux, N. S., Olson, L. B., Morrison, S. A., Llanga, T., Akinade, T., Zhu, Y., Zhong, Y., Bose, S., Arvai, S., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121393 · Cited by 83

Predictive ability of severity scores and outcomes for mortality in kidney transplant recipients with coronavirus disease 2019 admitted to the intensive care unit: results from a Brazilian single-center cohort study

Peruzzo, M. B., Requião‐Moura, L., Nakamura, M. R., Viana, L. A., Cristelli, M. P., Junior, H. T. S., & Medina-Pestana, J. O. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 80

Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials

Horowitz, R. I., & Freeman, P. R. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109851 · Cited by 79

Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation

Böhm, M., Frey, N., Giannitsis, E., Sliwa, K. S., & Zeiher, A. M. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01656-3 · Cited by 80

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

Li, C., Jiang, J., Wang, F., Zhou, N., Veronese, G., Moslehi, J. J., Ammirati, E., & Wang, D. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.008 · Cited by 82

Fatores associados ao óbito hospitalar por COVID-19 no Espírito Santo, 2020

Maciel, E. L. N., Jabor, P. M., Gonçalves, E., Sá, R. T., Lima, R. D. C. D., Reis-Santos, B., Lira, P. S., Bussinguer, E. C. D. A., & Zandonade, E. (2020) · Epidemiologia e Serviços de Saúde · doi:10.1590/s1679-49742020000400022 · Cited by 79

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis

Gorham, J., Moreau, A., Corazza, F., Peluso, L., Ponthieux, F., Talamonti, M., Izzi, A., Nagant, C., Djangang, N. N., Garufi, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244628 · Cited by 79

Decoding Clinical Biomarker Space of COVID-19: Exploring Matrix Factorization-based Feature Selection Methods

Saberi-Movahed, F., Mohammadifard, M., Mehrpooya, A., Rezaei-Ravari, M., Berahmand, K., Rostami, M., Karami, S., Najafzadeh, M., Hajinezhad, D., Jamshidi, M., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105426 · Cited by 80

The pediatric solid organ transplant experience with COVID‐19: An initial multi‐center, multi‐organ case series

Goss, M. B., Galván, N. T. N., Ruan, W. H., Muñoz, F. M., Brewer, E. D., O'Mahony, C. A., Melicoff, E., Dreyer, W. J., Miloh, T., Cigarroa, F. G., et al. (2020) · Pediatric Transplantation · doi:10.1111/petr.13868 · Cited by 77

Cardiovascular Manifestations and Mechanisms in Patients with COVID-19

Dou, Q., Wei, X. C., Zhou, K., Yang, S., & Jia, P. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.10.001 · Cited by 82

Using the Health Belief Model to Understand Age Differences in Perceptions and Responses to the COVID-19 Pandemic

Bechard, L., Bergelt, M., Neudorf, B., DeSouza, T. C., & Middleton, L. E. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.609893 · Cited by 91

Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19

Wu, C.-P., Adhi, F., & Highland, K. B. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc015 · Cited by 77

O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares

Aşkın, L., Tanrıverdi, O., & Aşkın, H. Ş. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200273 · Cited by 91

Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19

Fudim, M., Qadri, Y. J., Ghadimi, K., MacLeod, D. B., Molinger, J., Piccini, J. P., Whittle, J., Wischmeyer, P. E., Patel, M. R., & Ulloa, L. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10031-6 · Cited by 77

Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm

González-Rubio, J., Navarro-López, C., López-Nájera, E., López-Nájera, A., Jiménez‐Díaz, L., Navarro‐López, J. D., & López, A. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01359 · Cited by 76

A Systematic Review of COVID-19 and Myocarditis

Kariyanna, P. T., Sutarjono, B., Grewal, E., Singh, K. P., Aurora, L., Smith, L., Chandrakumar, H. P., Jayarangaiah, A., Goldman, S. A., Salifu, M. O., et al. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-8-9-11 · Cited by 77

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

Pfeifer, M., Ewig, S., Voshaar, T., Randerath, W. J., Bauer, T. T., Geiseler, J. G., Dellweg, D., Westhoff, M., Windisch, W., Schönhofer, B., et al. (2020) · Respiration · doi:10.1159/000509104 · Cited by 78

Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease

Whetton, A. D., Preston, G. W., Abubeker, S., & Geifman, N. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00326 · Cited by 77

Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study

Mousavi, S. A., Rad, S., Rostami, T., Rostami, M., Mousavi, S. A., Mirhoseini, S. A., & Kiumarsi, A. (2020) · Hematology · doi:10.1080/16078454.2020.1833435 · Cited by 77

Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study

Wang, G., Wang, Q., Wang, Y., Liu, C., Wang, L., Chen, H., Jiao, T., Hu, C., Lei, X., Guo, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791348 · Cited by 85

Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis

Prasad, R., Patton, M. J., Floyd, J. L., Vieira, C. P., Fortmann, S., DuPont, M., Harbour, A., Jeremy, C. S., Wright, J., Lamendella, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169141 · Cited by 79

Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects

Dharra, R., Sharma, A. K., & Datta, S. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156287 · Cited by 82

Cytokines and COVID-19: friends or foes?

Rokni, M., Hamblin, M. R., & Rezaei, N. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1799669 · Cited by 77

Sustainable health promotion for the seniors during COVID-19 outbreak: a lesson from Tokyo

Aung, M. N., Yuasa, M., Koyanagi, Y., Aung, T. N. N., Moolphate, S., Matsumoto, H., & Yoshioka, T. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12684 · Cited by 76

17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection

Breithaupt‐Faloppa, A. C., Correia, C. D. J., Prado, C. M., Stilhano, R. S., Ureshino, R. P., & Moreira, L. F. P. (2020) · Clinics · doi:10.6061/clinics/2020/e1980 · Cited by 76

Echocardiographic characteristics of patients with SARS-CoV-2 infection

Stöbe, S., Richter, S., Seige, M., Stehr, S. N., Laufs, U., & Hagendorff, A. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01727-5 · Cited by 76

COVID-19 Therapeutic Options Under Investigation

Kaddoura, M., Ibrahim, M. A., Hijazi, G., Soudani, N., Audi, A., Alkalamouni, H., Haddad, S., Eid, A. H., & Zaraket, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01196 · Cited by 75

Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury

Chen, X., Guo, H., Li, Q., Zhang, C., Deng, Q., & Leng, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02056 · Cited by 77

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies

Samidurai, A., & Das, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186790 · Cited by 82

COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department

Singer, M. V., Brahier, T., Ngai, M., Wright, J. K., Weckman, A. M., Erice, C., Meuwly, J., Hügli, O., Kain, K. C., & Boillat‐Blanco, N. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.001 · Cited by 73

An Artificial Intelligence Model to Predict the Mortality of COVID-19 Patients at Hospital Admission Time Using Routine Blood Samples: Development and Validation of an Ensemble Model

Ko, H., Chung, H., Kang, W. S., Park, C., Kim, D., Kim, S. E., Chung, C. R., Ko, R., Lee, H., Seo, J. H., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/25442 · Cited by 75

COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies

Calabretta, E., Moraleda, J. M., Iacobelli, M., Jara, R., Vlodavsky, I., O’Gorman, P., Pagliuca, A., Mo, C. C., Baron, R. M., Aghemo, A., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17240 · Cited by 75

Relative Lymphocytosis in COVID-19—A Ray of Hope

Ish, P., Malhotra, N., Agrawal, S. P., & Gupta, N. (2020) · Advances in respiratory medicine · doi:10.5603/arm.a2020.0098 · Cited by 11

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Wang, K., Zhang, Z., Yu, M., Tao, Y., & Xie, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06047-w · Cited by 87

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective StudyPreprint

Zhang, S., Guo, M., Duan, L., Wu, F., Wang, Z., Xu, J., Ma, Y., Lv, Z., Tan, X., Zhang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551390 · Cited by 8

“Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.

European Respiratory Society (2020) · European Respiratory Journal · doi:10.1183/13993003.50524-2020 · Cited by 18

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su, M., Yuan, J., Peng, J., Wu, M., Yang, Y., & Peng, Y. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.109927 · Cited by 5